BI
BioSyent Inc.
BIOYF · OTC
$11.35 -0.44% (-$0.05)
1M +6.97%
Market Cap $179.6M
P/E Ratio 18.19x
Div. Yield 1.34%
ROE 22.92%
Bulios Fair Price
$13.77
21.3% upside
Trenutna cena
$11.35
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BIOYF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
71 /100
Cheap PEG 0.84x
P/E 18.19x
P/B 3.92x
Growth
92 /100
Growing FCF growth 29.22%
EPS growth 21.03%
Book val. growth 7.49%
Profitability
98 /100
Strong Op. margin 23.21%
Gross margin 70.20%
FCF margin 21.18%
Quality
96 /100
Excellent ROA 16.32%
ROIC 19.41%
Asset turnover 0.92x
Debt
100 /100
Low Int. coverage 123.37x
Debt/Equity 0.07x
Net debt/EBITDA -0.14x
Stability
100 /100
Stable EPS volatility 0.75%
Beta 0.63x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIOYF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
René C. Goehrum
Employees
711
Headquarters
Mississauga
Prihajajoči dogodki
19 NOV.
Earnings
Upcoming earnings report